30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

James Schoonover

Insider profile

Currently holds positions in Abundia Global Impact Group Inc and MEDTOX Scientific Inc

Performance

Overall performance
2.4

Performance over holding periods
2.4
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 31% 68% 82%
Transactions
3 67% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Interim Chief Executive Officer, Director Abundia Global Impact Group Inc June 5, 2018 -
Vice President - Sales and Marketing and Chief Marketing Officer MEDTOX Scientific Inc July 17, 2000 -
Director Abundia Global Impact Group Inc April 13, 2018 - June 5, 2018

James Schoonover's trades of Abundia Global Impact Group Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2023-05-18 2023-05-18 B Purchase
61,941 +34.2%
460.81
US$1,456,006
61,941 +34.2% 460.81 US$1,456,006
2022-09-02 2022-09-02 B Purchase
44,452 -34.1%
341.14
US$487,459
44,452 -34.1% 341.14 US$487,459
2021-01-28 2021-01-26 S Sale
30,442 -37.8%
463.78
US$1,786,034
30,442 -37.8% 463.78 US$1,786,034